• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY VISIAN ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY VISIAN ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS Back to Search Results
Model Number MICL13.2
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Cyst(s) (1800); Visual Impairment (2138)
Event Type  Injury  
Event Description
The reporter stated the surgeon implanted a 13.2mm micl13.2 implantable collamer lens into the patient's right eye (od) on (b)(6) 2014.The lens was explanted on (b)(6) 2014 due to the development of a cyst behind the iris and the patient complained of not being able to read.The lens was explanted with no patient injury and a multifocal lens was implanted.The patient is doing well and the va is 20/25.
 
Manufacturer Narrative
(b)(4).Device evaluated by manufacturer? no, lens not returned.Evaluation: method: work order search.Results: a lens work order search was performed and no similar complaints were found within the work order.Conclusions: based on the complaint history and work order search, a specific root cause of the event could not be determined.(b)(4).
 
Manufacturer Narrative
Method: device history record review.Results: a review of the device history record was performed and nothing was found in the manufacturing, sterilization and packaging processes of this lens that was the root cause of the complaint.It is unlikely that the icl was the cause of this adverse event.Every icl undergoes a steam sterilization process.Before releasing the lens, quality department verifies the following for each icl lot: sterilization cycle parameters (time, temperature and pressure) must be met.Biological indicators used for every sterilization batch must be in accordance with specifications to demonstrate sterility.Lal testing must be in accordance with specifications to ensure that the product is free from any endotoxin.(b)(4).
 
Manufacturer Narrative
Method: medical review.Results: per medical review - reportedly, by hcp from the facility, the icl was explanted 3 months postoperatively to address development of a cyst behind the iris.An multifocal iol was implanted successfully at the same surgery date and va was 20/25.According to the reporter it is unknown if the cyst was present before icl implantation.It should be noted that there are two type of iris cysts: primary (arise from iris pigment epithelium or iris stroma; usually asymptomatic) and secondary (following intraocular surgery, ocular trauma or prolonged use of miotics; could enlarge and lead to complications).Given all this information it is very likely that either patient factor (pre-existing ocular condition) and/or procedure related factor (cyst as a postoperative complication) have caused the reported event.Conclusions: based on the complaint history, work order search and the medical review, a likely cause of the event is either patient factor (pre-existing ocular condition) and/or procedure related factor (cyst as a postoperative complication).(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISIAN ICL (IMPLANTABLE COLLAMER LENS)
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-25 60
SZ  CH-2560
Manufacturer (Section G)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-2 560
SZ   CH-2560
Manufacturer Contact
althea watson
1911 walker avenue
monrovia, CA 91016
6263037902
MDR Report Key3907625
MDR Text Key4663229
Report Number2023826-2014-00510
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date09/30/2015
Device Model NumberMICL13.2
Other Device ID NumberDIOPTER -11.5
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/11/2015
Initial Date FDA Received07/01/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received09/16/2014
02/19/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/14/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTRIDGE MODEL AND LOT NUMBER UNK; INJECTOR MODEL AND LOT NUMBER UNK
Patient Outcome(s) Required Intervention;
Patient Age25 YR
-
-